Best Life Sciences Companies in Andalusia, Spain
The 45 best Life Sciences companies in Andalusia, Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: UDX.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Andalusia
| # | Company | Last round | Disclosed funding | Stage | Founder | Employees | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Biat Group Platform offering solutions for toxicity testing | — | — | Unfunded | — | 19 | WordPressMySQLPHP+33 | — | — |
| 2 | Biogenox Provider of genetic diagnosis genetic for personalized health and wellness insights | — | — | Unfunded | Esther Chacon CEO | — | — | — | — |
| 3 | Cesa-Alliance Develops Omni spectrum molecules | — | — | Unfunded | Reiner van Tilborg CEO | — | — | — | — |
| 4 | CRISPNA Developer of a genome editing tool based on CRISPR technology | — | — | Unfunded | Araceli Gonzalez Co-Founder | — | — | — | — |
| 5 | Gennova Scientific Reagents for protein biology | — | — | Unfunded | Carmen Perez Casanes CEO | — | — | — | — |
| 6 | Genome7 Provider of next-generation sequencing (NGS) and bioinformatics services for cancer research | — | — | Deadpooled | Eduardo Pareja CEO | — | — | — | — |
| 7 | Genycell Biotech Offers products and services in molecular biology | — | — | Acquired | Javier Martin Hernandez Ceo( Consejero Delegado) | — | — | — | — |
| 8 | Innovaxis Offers regenerative medicine products and services | — | — | Deadpooled | Manuel Esteban Founder | — | — | — | — |
Top 12 Life Sciences companies in Andalusia
#1
Series C · Seville, Andalusia · founded 2012 · 61 employees$126.1Mraised▾
Developer of non-invasive blood-based diagnostics for cancer. The company is developing a screening test that uses metabolomics to analyze patient blood samples and detect early signs of disease. It has developed tests for the early detection of colorectal cancer, lung cancer, and breast cancer.
- Jan 2026Series C$35M
- Feb 2025Venture Debt$21M
- Aug 2024Series B—
- Nov 2023Series B$70M
#2
Series A · Seville, Andalusia · founded 2011 · 8 employees$13.6Mraised▾
Vaxdyn, a spin-off of the University HospitalVirgen del Rocío is focussed on developing vaccines and mAbs against infections caused by multiresistant bacteria. Its lead compound VXD-001 is a preventive vaccine currently in the late preclinical phase for the treatment of A.baumannii infection. It is also developing a prophylactic vaccine which is in discovery phase against P.aeruginosa based on recombinant protein antigens. Additionally, it is developing VXD-003, an mAb in discovery phase for the treatment of A.baumannii infections.
- Sep 2024Grant (prize money)$2.8M
- Sep 2024Series A$13.3M
- Mar 2021Seed$357.3K
- Jul 2020Grant (prize money)—
#3
Seed · Seville, Andalusia · founded 2020$112.6Kraised▾
Developer of drugs to treat neurodegenerative diseases. The company's lead product is ONESTX-1 a combination with specific sulfated neurosteroid hormones such as DHEA-S for Parkinson's disease (PD) and Huntington's disease (HD).
- May 2025Seed$112.6K
#4
Seed · Almeria, Andalusia · founded 2007 · 275 employees$5.2Mraised▾
Developer of biotechnology and engineered products as alternatives to conventional synthetic chemicals in crop production. It offers products such as biopesticides, biostimulants and pre- and probiotics that support plant nutrition, health, soil microbiome balance, and pest or disease control.
- Nov 2022Grant (prize money)$490.8K
- Oct 2022Seed—
- Aug 2020Grant (prize money)$1.9M
- Jan 2019Grant (prize money)$76.4K
#5
Funding Raised · Seville, Andalusia · founded 2022$55.1Kraised▾
Developer of agitation systems for bio-fermentation reactors. It offers system that reduces the damage to cells and optimizes mixing in the vessel for development of vaccines and cultures.
- Sep 2024Grant (prize money)$55.1K
- Oct 2023Grant (prize money)—
#6
Seed · Granada, Andalusia · founded 2015 · 22 employees$1.1Mraised▾
Developer of 3D bioprinting and regenerative medicine. The company uses 3D printing technologies for regenerative therapies. Bioprinter is a device that can manufacture 3D parts with a customized external structure and a meshed internal structure from different materials, seeded with cells. The first version of the bioprinter is focused to treat cartilage degeneration and degenerative joint diseases. Bioprinted 3D structures can also be used for drug development.
- Jan 2023Grant (prize money)$196.6K
- May 2022Seed$554.9K
- Oct 2020Seed$580.3K
- Jan 2020Grant (prize money)$281.5K
#7
Deadpooled · Armilla, Andalusia · founded 2010 · 17 employees$9.3Mraised▾
nLife Therapeutics is focussed on the development of cell-specific oligonucleotides as therapeutic agents for CNS disorders. It is developing a delivery platform, a two-component design which has a small drug that targets the selected group of cells and siRNAs / antisense oligonucleotides that reduce the amount of disease-related protein. Its lead candidate NLF-PD 1233 targets alpha-synuclein and reduce its accumulation which causes Parkinson's disease. It is also developing NLF-HD for Huntington disease, which reduces the level of altered Htt in striatal and cortical neurons thus stopping the disease progression.
- Jun 2014Series A$2.7M
- Feb 2012Series A$6.6M
#8
Acqui-Hired · Seville, Andalusia · founded 1996 · 17 employees$2.2Mraised▾
PEVESA Biotech is a biotechnology company focused on research and development, design and production of amino acids, peptides and plant based hydrolyzation.The formulas and ingredients developed are applicable to the following sectors: Bioagriculture, Human Food and Nutraceuticals, Baby food and clinical nutrition, Animal Health, Industrial Fermentations, Cosmetics. In the past 3 years, they have developed around 200 formulas and ingredients, of which 50 are currently on the market.
- Apr 2013Unattributed$1.6M
#9
Series A · Granada, Andalusia · founded 2004$630.9Kraised▾
Provider of services in Next Generation Sequencing (NGS) and Bioinformatics services. Its business model is based on assisting the customers along with the complete NGS project, from project design and sequencing to expert bioinformatics analyses, consultancy, and tailored software development. It is granted 430 K to develop a bioinformatics platform integrated with the Electronic Health Record for human microbiome analysis.
- Jan 2018Grant (prize money)$297.7K
- Jan 2017Series A$630.9K
- Jan 2016Grant (prize money)$430K
- Nov 2015Grant (prize money)$100K
#10
Deadpooled · Seville, Andalusia · founded 2002$785Kraised▾
Provider of designs and implements genetic markers/biomarkers for various diseases. The company offers genomic study services and hypothesis-free clinical cloning data analysis. In addition, it owns and operates a commercial biobank with biospecimens for various types of cancers, melanoma, osteoporosis, diabetes, colon cancer, cardiovascular risk, Alzheimer’s disease, asthma/allergy, rheumatoid arthritis, schizophrenia, and reproductive diseases.
- Mar 2006Seed$785K
#11
Funding Raised · Seville, Andalusia · founded 2000 · 32 employees$183Kraised▾
Biomedal is a biotechnology company focused on development and commercialization of products for bioindustry and diagnostics. The company operates as Biomedal Life Science and Biomedal Diagnostics. The diagnostic division offers diagnostics products and solutions for celiac disease diagnosis, gluten free diet monitoring and other auto-immune disease markers for post-transplant rejection detection (IVYLISA anti-GSTT1). The Gluten immunogenic peptide test is available in both formats ELISA and Immunochromatographic assay. It also offers a test kit to analyze the quality of used frying oil. The life science division is engaged in the development of tools for bioprocess industry such as a system for protein expression (CASCADE™), protein purification systems (HISTAG and LYTAG), affinity resins, cloning vectors and strains. It also operates as a CRO (Contract Research Organization).
- Jan 2022Grant (prize money)$183K
#12
Deadpooled · Granada, Andalusia · founded 2016 · 2 employees$415.9Kraised▾
Provider of consumer genomic solutions and personalized treatments. The company offers DNA test solutions for nutrition, physical activity, and disease risk. Also, it performs tests for diseases like diabetes, osteoporosis, celiac disease, etc. The company offers its services through third-party pharmacies.
- Mar 2019Seed$415.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Spain
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,045 Spain-affiliated papers.
- Universidad Internacional De La Rioja128
- Consejo Superior de Investigaciones Científicas40
- Universidad Complutense de Madrid29
- Universidade de Santiago de Compostela27
- University of Córdoba26
- Population1→5
- Flow cytometry1→5
- Mutant1→4
- DNA damage3→4
- Gene1→15
- Agriculture1→15
- Health benefits2→9
- Germplasm1→8
- In vivo2→8
- Agriculture2→15
- Context (archaeology)1→13
- Antibiotic resistance2→11
- Antimicrobial1→9
- Production (economics)1→9
Where biotechnology is researched across Spain
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.